Hay DW - Search Results

1

SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence.

Underwood DC, Osborn RR, Kotzer CJ, Adams JL, Lee JC, Webb EF, Carpenter DC, Bochnowicz S, Thomas HC, Hay DW, Griswold DE. Underwood DC, et al. Among authors: hay dw. J Pharmacol Exp Ther. 2000 Apr;293(1):281-8. J Pharmacol Exp Ther. 2000. PMID: 10734180

2

Nonpeptide tachykinin receptor antagonists. III. SB 235375, a low central nervous system-penetrant, potent and selective neurokinin-3 receptor antagonist, inhibits citric acid-induced cough and airways hyper-reactivity in guinea pigs.

Hay DW, Giardina GA, Griswold DE, Underwood DC, Kotzer CJ, Bush B, Potts W, Sandhu P, Lundberg D, Foley JJ, Schmidt DB, Martin LD, Kilian D, Legos JJ, Barone FC, Luttmann MA, Grugni M, Raveglia LF, Sarau HM. Hay DW, et al. J Pharmacol Exp Ther. 2002 Jan;300(1):314-23. doi: 10.1124/jpet.300.1.314. J Pharmacol Exp Ther. 2002. PMID: 11752131

3

Pharmacological characterization of GSK573719 (umeclidinium): a novel, long-acting, inhaled antagonist of the muscarinic cholinergic receptors for treatment of pulmonary diseases.

Salmon M, Luttmann MA, Foley JJ, Buckley PT, Schmidt DB, Burman M, Webb EF, DeHaas CJ, Kotzer CJ, Barrett VJ, Slack RJ, Sarau HM, Palovich MR, Lainé DI, Hay DW, Rumsey WL. Salmon M, et al. Among authors: hay dw. J Pharmacol Exp Ther. 2013 May;345(2):260-70. doi: 10.1124/jpet.112.202051. Epub 2013 Feb 22. J Pharmacol Exp Ther. 2013. PMID: 23435542

4

The bronchopulmonary pharmacology of SK&F 104353 in anesthetized guinea pigs: demonstration of potent and selective antagonism of responses to peptidoleukotrienes.

Torphy TJ, Newton JF, Wasserman MA, Vickery-Clark L, Osborn RR, Bailey LS, Yodis LA, Underwood DC, Hay DW. Torphy TJ, et al. Among authors: hay dw. J Pharmacol Exp Ther. 1989 May;249(2):430-7. J Pharmacol Exp Ther. 1989. PMID: 2542530

5

Pharmacological characterization of SB 202235, a potent and selective 5-lipoxygenase inhibitor: effects in models of allergic asthma.

Chabot-Fletcher MC, Underwood DC, Breton JJ, Adams JL, Kagey-Sobotka A, Griswold DE, Marshall LA, Sarau HM, Winkler JD, Hay DW. Chabot-Fletcher MC, et al. Among authors: hay dw. J Pharmacol Exp Ther. 1995 Jun;273(3):1147-55. J Pharmacol Exp Ther. 1995. PMID: 7791085

6

Comparison of phosphodiesterase III, IV and dual III/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea pigs.

Underwood DC, Kotzer CJ, Bochnowicz S, Osborn RR, Luttmann MA, Hay DW, Torphy TJ. Underwood DC, et al. Among authors: hay dw. J Pharmacol Exp Ther. 1994 Jul;270(1):250-9. J Pharmacol Exp Ther. 1994. PMID: 8035322

7

Differential antagonism of airway contractile responses to prostaglandin (PG)D2 and 9 alpha, 11 beta-PGF2 by atropine, SK&F 88046 and SQ 29,548 in the guinea pig.

Underwood DC, Muccitelli RM, Luttmann MA, Hay DW, Torphy TJ, Wasserman MA. Underwood DC, et al. Among authors: hay dw. J Pharmacol Exp Ther. 1994 Jan;268(1):304-10. J Pharmacol Exp Ther. 1994. PMID: 8301572

8

Persistent airway eosinophilia after leukotriene (LT) D4 administration in the guinea pig: modulation by the LTD4 receptor antagonist, pranlukast, or an interleukin-5 monoclonal antibody.

Underwood DC, Osborn RR, Newsholme SJ, Torphy TJ, Hay DW. Underwood DC, et al. Among authors: hay dw. Am J Respir Crit Care Med. 1996 Oct;154(4 Pt 1):850-7. doi: 10.1164/ajrccm.154.4.8887574. Am J Respir Crit Care Med. 1996. PMID: 8887574

9

Nonpeptide tachykinin receptor antagonists: I. Pharmacological and pharmacokinetic characterization of SB 223412, a novel, potent and selective neurokinin-3 receptor antagonist.

Sarau HM, Griswold DE, Potts W, Foley JJ, Schmidt DB, Webb EF, Martin LD, Brawner ME, Elshourbagy NA, Medhurst AD, Giardina GA, Hay DW. Sarau HM, et al. Among authors: hay dw. J Pharmacol Exp Ther. 1997 Jun;281(3):1303-11. J Pharmacol Exp Ther. 1997. PMID: 9190866

10

Nonpeptide endothelin receptor antagonists. X. Inhibition of endothelin-1- and hypoxia-induced pulmonary pressor responses in the guinea pig by the endothelin receptor antagonist, SB 217242.

Underwood DC, Bochnowicz S, Osborn RR, Luttmann MA, Hay DW. Underwood DC, et al. Among authors: hay dw. J Pharmacol Exp Ther. 1997 Dec;283(3):1130-7. J Pharmacol Exp Ther. 1997. PMID: 9399985

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

128 results

Search Page

Filters